• 杨贝 博士

    发布者:蒋京辰发布时间:2019-11-14浏览次数:7249

      杨贝 博士

    课题组长, 研究员, 助理教授,博士生导师

    Principal Investigator, Tenure-track Assistant Professor 

    Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University
    Email: yangbei@shanghaitech.edu.cn
    Tel: 021-20685590
    Laboratory: Lab of Pathogenic Biology

    Research Interest

    Research in our lab focuses on several high-risk infectious diseases and their causative microbes, including respiratory viruses, HIV-1 and plasmodium. We are particularly interested in:

    1)identifying novel sites of therapeutic and preventive vulnerabilities in these microbial pathogens;

    2)rational screen and development of potential antivirals against their infections;

    3)structure-guided engineering & functional reshaping of host factors for the treatment or prevention of these high-risk infectious diseases.

    Expertise  

    Integrative Structural Biology, Structural Proteomics 


    Biography

    2004 B.S.    National Talents Training Program, College of Life Sciences, Wuhan University

    2010 Ph.D. of Biochemistry and Molecular Biology, Institute of Biochemistry and Cell Biology, Chinese Academy of Science

    2010-2013 Visiting Fellow, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S.

    2013-2015 Postdoctoral Scholar, Department of Molecular and Cell Biology, University of California, Berkeley, U.S.

    2015.11-2020.09 Co-PI, Research Associate Professor, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China

    2020.09-present Principle investigator & Tenure-track assistant professor, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China


    Selected Awards and Honors

    2017  Young Scholar, Natural Science Foundation of China

    2016  Pujiang Scholar, Science and Technology Commission of Shanghai Municipality

    Selected Publications: (* co-first author, # correspondence author)      

    1. Wang LJ*, Xue W*, Zhang HX*, Gao RZ*, Qiu HY*, Wei J, Zhou LN, Lei YN, Wu XC, Li X, Liu CF, Wu J, Chen QB, Ma HH, Huang XX, Cai C, Zhang Y,Yang B#, Yin H#, Yang L#, Chen J#. (2021) Eliminating genome-wide and transcriptome-wide off-target mutations by base editor. Nature Cell Biology, DOI:10.1038/S41556-021-00671-4

    2. Shi X*, Wan Y*, Wang N*, Xiang J*, Wang T, Yang X, Wang J, Dong X, Dong L, Yan L, Li Y, Liu L, Hou S, Zhong Z, Wilson IA, Yang B, Yang G#, Lerner RA#.(2021) Selection of a picomolar antibody that targets CXCR2-mediated neutrophil activation and alleviates EAE symptoms.Nature Communications, 12(1):2547

    3. Meng B, Lan KK, Xie J, Lerner RA, Wilson IA#, Yang B#. (2020) Inhibitory antibodies identify novel sites of therapeutic vulnerability in rhinovirus and other Enteroviruses. Proceedings of the National Academy of Sciences, 117 (24): 13499-13508

    4. Wang X*, Ding C*, Yu W*, Wang Y*, He S*, Yang B*, Xiong YC, Wei J, Li J, Liang J, Lu Z, Zhu W, Wu J, Zhou Z, Huang X, Liu Z#, Yang L#, Chen J#. (2020) Cas12a Base Editors Induce Efficient and Specific Editing with Low DNA Damage Response. Cell Report, 31(9):107723

    5. Cui YR*, Wang SJ*, Chen J, Li J, Chen W, Wang S, Meng B, Zhu W, Zhang Z, Yang B, Jiang B, Yang G, Ma P#., Liu J#. (2020) Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides. Genome Biology, 21(1):51

    6. Yang L#, Yang B#, Chen J#. (2019) One Prime for All Editing. Cell,179(7):1448-1450

    7. Xu JC*, Cui KJ*, Shen LQ, Shi J, Li LT, You LL, Fang CL, Zhao GP#, Feng Y#, Yang B#, Zhang Y#. (2019) Crl activates transcription by stabilizing active conformation of the master stress transcription initiation factor. eLife,8: e50928

    8. Zhao Q*, Ren C*, Liu L, Chen J, Shao Y, Sun N, Sun R, Kong Y, Ding X, Zhang X, Xu Y, Yang B, Yin Q#, Yang X#, Jiang B#. (2019) Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase. Journal of Medicinal Chemistry, 62(20):9281-9298

    9. Wang Y*, Gao R*, Wu J, Xiong YC, Wei J, Zhang S, Yang B, Chen J#, Yang L#. (2019) Comparison of cytosine base editors and development of the BEable-GPS database for targeting pathogenic SNVs. Genome Biology, 20(1):218

    10. Xia S, Yan L, Xu W, Agrawal AS, Algaissi A, Tseng CK, Wang Q, Du L, Tan W, Wilson IA#, Jiang S#, Yang B#, Lu L#. (2019) A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Science Advances, 5(4): eaav4580

    11. Chen J#, Yang B#, Yang L#. (2019) To BE or not to BE, that is the question. Nature Biotechnology, 37(5):520-522

    12. Yang B#, Yang L# and Chen J#. (2019) Development and Application of Base Editors. TheCRISPR Journal, 2: 91-104

    13. Yan L, Meng B, Xiang J, Wilson IA# & Yang B#. (2018) Crystal structure of the post-fusion core of the Human coronavirus 229E spike protein at 1.86Å resolution. Acta Crystallographica Section D, 74(Pt 9):841-851

    14. Wang X*, Li J*, Wang Y*, Yang B*, Wei J, Wu J, Wang R, Huang X#, Chen J#, Yang L#. (2018) Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion. Nature Biotechnology, 36(10):946-949 

    15. Qiang M, Dong X, Zha Z, Zuo XK, Song XL, Zhao LX, Yuan C, Huang C, Tao PD, Hu Q, Li WG, Hu WH, Li J, Nie Y, Buratto D, Zonta F, Ma PX, Yu Z, Liu LL, Zhang Y, Yang B, Xie J, Xu TL, Qu ZH#, Yang G#, Lerner RA#. (2018) Selection of an ASIC1a-blocking combinatorial antibody that protects cells from ischemic death. Proceedings of the National Academy of Sciences, 115(32): E7469-E7477

    16. Li X*, Wang Y*, Liu Y*, Yang B*, Wang X, Wei J, Lu Z, Zhang Y, Wu J, Huang X#, Yang L#, Chen J#. (2018) Base editing with a Cpf1-cytidine deaminase fusion. Nature Biotechnology, 36(4):324-327

    17. Lei L*, Chen H*, Xue W*, Yang B*, Hu B*, Wei J, Wang L, Cui Y, Li W, Wang J, Yan L, Shang W, Gao J, Sha J, Zhuang M, Huang X, Shen B#, Yang L#, Chen J#. (2018) APOBEC3 induces mutations during repair of CRISPR-Cas9-generated DNA breaks. Nature Structural & Molecular Biology, 25(1):45-52

    18. Wang L*, Xue W*, Yan L*, Li X, Wei J, Chen M, Wu J, Yang B#, Yang L#, Chen J#. (2017) Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor. Cell Research, 27(10):1289-1292

    19. Yang B#, Li X, Lei L, Chen J#. (2017) APOBEC: From mutator to editor. Journal of Genetics and Genomics, 44(9):423-437

    20. Yang B, Stjepanovic G, Shen Q, Martin A, Hurley JH#. (2015) Vps4 disassembles an ESCRT-III filament by global unfolding and processive translocation. Nature Structural & Molecular Biology, 22(6):492-8

    21. Hurley JH#, Yang B. (2014) Making sense of Vps4. The Journal of Molecular Biology, 426(3):503-6

    22. Yang B, Zhong C, Peng Y, Lai Z, Ding J#. (2010)Molecular mechanisms of off-on switch of activities of human IDH1 by tumor-associated mutation R132H. Cell Research, 20:1188-1200 (Cover story)

    23. Dong X*, Yang B*, Li Y, Zhong C, Ding J#. (2009) Molecular basis of the acceleration of the GDP-GTP exchange of human ras homolog enriched in brain by human translationally controlled tumor protein. The Journal of Biological Chemistry, 284:23754-23764

    24. Dong X*, Zhou M*, Zhong C, Yang B, Shen N, Ding J#. (2009) Crystal structure of Pyrococcus horikoshii tryptophanyl-tRNA synthetase and structure-based phylogenetic analysis suggest an archaeal origin of tryptophanyl-tRNA synthetase. Nucleic Acids Research, 38:1401-1412

    25. Shen N, Zhou M, Yang B, Yu Y, Dong X, Ding J#. (2008) Catalytic mechanism of the tryptophan activation reaction revealed by crystal structures of human tryptophanyl-tRNA synthetase in different enzymatic states. Nucleic Acids Research, 36:1288-1299

    26. Shen N*, Guo L*, Yang B, Jin Y and Ding J#. (2006) Structure of human tryptophanyl-tRNA synthetase in complex with tRNATrp reveals the molecular basis of tRNA recognition and specificity. Nucleic Acids Research, 34:3246-3258





    意昂专业提供:意昂意昂平台𓀂、意昂官网等服务,提供最新官网平台、地址、注册、登陆、登录、入口、全站、网站、网页、网址、娱乐、手机版、app、下载、欧洲杯、欧冠、nba、世界杯、英超等,界面美观优质完美,安全稳定,服务一流,意昂欢迎您。